PDS Biotechnology (PDSB) Tax Rate (2014 - 2025)

PDS Biotechnology's (PDSB) quarterly Tax Rate came in at 99.03% in Q4 2025, up 717.67% on a QoQ basis from 12.11% in Q1 2025.

PDS Biotechnology (PDSB) Tax Rate (2014 - 2025) Analysis & Trends

PDS Biotechnology (PDSB) has 7 years of Tax Rate data on file, last reported at 99.03% in Q4 2025.

Quarterly Tax Rate changed N/A year-over-year to 99.03% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 24.28% (up 2202.0% YoY) and the FY2025 annual result came in at 21.0%, up 1874.0% from the prior year.
Tax Rate rose to 99.03% in Q4 2025, from 12.11% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 99.03% in Q4 2025 to a low of 0.01% in Q4 2022.
A 5-year average of 29.63% and a median of 11.49% in 2025 frame the typical range for Tax Rate.
Annual changes were most pronounced in 2022 — Tax Rate slumped 7138 bps — and 2023, when it gained 1 bps.
Tracing PDSB's Tax Rate over 5 years: stood at 88.46% in 2021, then slumped by 100 bps to 0.01% in 2022, then soared by 100 bps to 0.0% in 2023, then surged by 51496902 bps to 9.45% in 2024, then surged by 948 bps to 99.03% in 2025.
The last three Tax Rate figures came in at 99.03% (Q4 2025), 12.11% (Q1 2025), and 9.45% (Q2 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	15.11%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	10.91%
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	7.49%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-16.71%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	34.12%
10	PDS Biotechnology	11.58 Mn	11.58 Mn	-	-

Download Data